Investors

The Company’s current investors include:

Abingworth Management
www.abingworth.com

Cancer Research Ventures
www.cancertechnology.com

Essex Woodlands Healthcare Ventures
www.essexwoodlands.com

Gilde Investment Management
www.gilde.nl

Nomura Phase4 Ventures
www.nomura.com/npv

The Institute of Cancer Research
www.icr.ac.uk

The University of Cambridge
www.cam.ac.uk

The Wellcome Trust
www.wellcome.ac.uk

Search
Latest News

Chroma and GSK enter into major collaboration to discover macrophage-targeted drugs

Chroma raises £15 million in Series D financing

Featured Programme
Cell Accumulation Approach